These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11850584)

  • 1. Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma.
    Kim HC; Kim HJ; Kim JC
    J Korean Med Sci; 2002 Feb; 17(1):23-8. PubMed ID: 11850584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
    Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
    Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma.
    Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
    PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma.
    Cabibi D; Calascibetta A; Aragona F; Martorana A; Campione M; Sanguedolce R
    Anticancer Res; 2009 Nov; 29(11):4417-22. PubMed ID: 20032387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal signet ring cell carcinoma: Influence of EGFR, E-cadherin and MMP-13 expression on clinicopathological features and prognosis.
    Foda AAM; Aziz AA; Mohamed MA
    Ann Diagn Pathol; 2018 Feb; 32():41-46. PubMed ID: 29414397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced E-Cadherin and Aberrant β-Catenin Expression are Associated With Advanced Disease in Signet-Ring Cell Carcinomas.
    Ma YR; Ren Z; Conner MG; Siegal GP; Wei S
    Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):432-438. PubMed ID: 26808130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.
    Sentani K; Oue N; Tashiro T; Sakamoto N; Nishisaka T; Fukuhara T; Taniyama K; Matsuura H; Arihiro K; Ochiai A; Yasui W
    Am J Surg Pathol; 2008 Aug; 32(8):1182-9. PubMed ID: 18580680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.
    Tung SY; Wu CS; Chen PC
    Am J Gastroenterol; 1996 Oct; 91(10):2195-9. PubMed ID: 8855747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer.
    Kojima M; Shiokawa A; Ohike N; Tamegai Y; Kato H; Morohoshi T
    Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas.
    Lee HJ; Lee OJ; Jang KT; Bae YK; Chung JY; Eom DW; Kim JM; Yu E; Hong SM
    Am J Clin Pathol; 2013 Feb; 139(2):167-76. PubMed ID: 23355201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas.
    van der Wurff AA; Vermeulen SJ; van der Linden EP; Mareel MM; Bosman FT; Arends JW
    J Pathol; 1997 Jul; 182(3):325-30. PubMed ID: 9349236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
    El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
    Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas.
    Nakamura E; Sugihara H; Bamba M; Hattori T
    J Pathol; 2005 Feb; 205(3):349-58. PubMed ID: 15682444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reacquisition of E-cadherin expression in metastatic deposits of signet-ring cell carcinoma of the upper gastrointestinal system: a potential anchor for metastatic deposition.
    Ma YR; Siegal GP; Wei S
    J Clin Pathol; 2017 Jun; 70(6):528-532. PubMed ID: 27864451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadherin-catenin expression in primary colorectal cancer: a survival analysis.
    Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR
    Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signet ring cell differentiation in mucinous colorectal carcinoma.
    Börger ME; Gosens MJ; Jeuken JW; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
    J Pathol; 2007 Jul; 212(3):278-86. PubMed ID: 17471475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.